Meanwhile, the BSE Sensex was up 61.50 points, or 0.35%, to 17,580.76
On BSE, 5.09 lakh shares were traded in the counter as against an average daily volume of 43,313 shares in the past one quarter.
The stock hit a 52-week high of Rs 53.70 in intra-day trade today, 19 March 2010. The stock hit a low of Rs 46.40 so far during the day. The stock had hit a 52-week low of Rs 11.10 on 18 March 2009.
The small-cap stock outperformed the market over the past one month till 18 March 2010, gaining 26.23% as compared to the Sensex's 7.30% rise. It had also outperformed the market in the past one quarter, surging 37.22% as compared to the Sensex's return of 4.78%.
The company's equity capital is Rs 9.66 crore. Face value per share is Rs 2.
The current price of Rs 46.90 discounts the company's Q3 December 2009 annualized EPS of Rs 8.70, by a PE multiple of 5.39
Shasun Chemicals & Drugs is engaged in the manufacture of active pharmaceutical ingredients and drug products with a significant presence in the anti-inflammatory and anti-ulcerative therapeutic groups.
The company posted net profit of Rs 10.50 crore in Q3 December 2009 as compared to net loss of Rs 13.50 crore in Q3 December 2009. Net sales rose 15.30% to Rs 144.02 crore in Q3 December 2009 over Q3 December 2008.